Detalhe da pesquisa
1.
Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial.
Biomarkers
; : 1-17, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804903
2.
Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1).
Nicotine Tob Res
; 22(4): 539-548, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722062
3.
Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2).
Nicotine Tob Res
; 22(4): 549-559, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125079
4.
Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland.
Regul Toxicol Pharmacol
; 81 Suppl 2: S139-S150, 2016 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27816672
5.
Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: A randomized controlled study in confinement.
Regul Toxicol Pharmacol
; 81: 489-499, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693654
6.
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.
Cancer Immunol Immunother
; 63(8): 787-96, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24770667
7.
Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels.
Toxicol Rep
; 10: 367-375, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926662
8.
Smoking and apolipoprotein levels: A meta-analysis of published data.
Toxicol Rep
; 9: 1150-1171, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518393
9.
Reduced levels of biomarkers of exposure in smokers switching to the Carbon-Heated Tobacco Product 1.0: a controlled, randomized, open-label 5-day exposure trial.
Sci Rep
; 10(1): 19227, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154508
10.
Exposure to harmful and potentially harmful constituents decreased in smokers switching to Carbon-Heated Tobacco Product.
Toxicol Lett
; 330: 30-40, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380119
11.
Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity.
Toxicol Rep
; 7: 1480-1486, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33204648
12.
Influence of smoking on levels of urinary 8-iso Prostaglandin F2α.
Toxicol Rep
; 6: 18-25, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30519530
13.
Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B2.
Toxicol Rep
; 5: 561-567, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29854626
14.
Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days.
Data Brief
; 10: 283-293, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27995164
15.
Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease.
Cancer Chemother Pharmacol
; 75(4): 701-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25627002